Please login to read the full article.
Scrip Regulatory Affairs
EMA consults on revised guideline on active substance master file procedure
24 January 2012
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- EMA proposes to update qualified persons requirements on drug certification, batch release
- Feedback sought on EMA reflection paper on clinical testing for tissue-engineered products
- EMA consults on extending guideline on excipients declared in drug labels, packaging
- EMA plans guidance on process validation of biotechnology-derived active substances
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
